These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18631970)

  • 1. Decision analytic models for Alzheimer's disease: state of the art and future directions.
    Cohen JT; Neumann PJ
    Alzheimers Dement; 2008 May; 4(3):212-22. PubMed ID: 18631970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Review of Model-Based Economic Evaluations of Treatments for Alzheimer's Disease.
    Hernandez L; Ozen A; DosSantos R; Getsios D
    Pharmacoeconomics; 2016 Jul; 34(7):681-707. PubMed ID: 26899832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Practical treatment strategies for patients with Alzheimer's disease.
    Christensen DD; Lin P
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S17-23. PubMed ID: 18664338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
    Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
    Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methodological issues in the economic analysis of cancer treatments.
    Tappenden P; Chilcott J; Ward S; Eggington S; Hind D; Hummel S
    Eur J Cancer; 2006 Nov; 42(17):2867-75. PubMed ID: 17023160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of group psychotherapy for depression in Uganda.
    Siskind D; Baingana F; Kim J
    J Ment Health Policy Econ; 2008 Sep; 11(3):127-33. PubMed ID: 18806302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health economic evaluations using decision analytic modeling. Principles and practices--utilization of a checklist to their development and appraisal.
    Soto J
    Int J Technol Assess Health Care; 2002; 18(1):94-111. PubMed ID: 11987445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers in Alzheimer's disease: not yet surrogate endpoints.
    Coley N; Andrieu S; Delrieu J; Voisin T; Vellas B
    Ann N Y Acad Sci; 2009 Oct; 1180():119-24. PubMed ID: 19906266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing health economic outcome in Alzheimer's disease clinical trials.
    Jonsson L
    J Nutr Health Aging; 2007; 11(4):353-5. PubMed ID: 17653498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
    Doody RS
    Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using outcomes data to identify best medical practice: the role of policy models.
    Matchar DB; Samsa GP
    Hepatology; 1999 Jun; 29(6 Suppl):36S-39S. PubMed ID: 10386082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinoma.
    Kim WR
    Clin Liver Dis; 2005 May; 9(2):225-34. PubMed ID: 15831270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health service utilization among Alzheimer's disease patients: evidence from managed care.
    Frytak JR; Henk HJ; Zhao Y; Bowman L; Flynn JA; Nelson M
    Alzheimers Dement; 2008 Sep; 4(5):361-7. PubMed ID: 18790463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primer: using decision analysis to improve clinical decision making in urology.
    Elkin EB; Vickers AJ; Kattan MW
    Nat Clin Pract Urol; 2006 Aug; 3(8):439-48. PubMed ID: 16902520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The basis for disease-modifying treatments for Alzheimer's disease: the Sixth Annual Mild Cognitive Impairment Symposium.
    Duara R; Barker W; Loewenstein D; Bain L
    Alzheimers Dement; 2009 Jan; 5(1):66-74. PubMed ID: 19118811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scales as outcome measures for Alzheimer's disease.
    Black R; Greenberg B; Ryan JM; Posner H; Seeburger J; Amatniek J; Resnick M; Mohs R; Miller DS; Saumier D; Carrillo MC; Stern Y
    Alzheimers Dement; 2009 Jul; 5(4):324-39. PubMed ID: 19560103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncertainty and sensitivity analyses of a decision analytic model for posteradication polio risk management.
    Duintjer Tebbens RJ; Pallansch MA; Kew OM; Sutter RW; Bruce Aylward R; Watkins M; Gary H; Alexander J; Jafari H; Cochi SL; Thompson KM
    Risk Anal; 2008 Aug; 28(4):855-76. PubMed ID: 18627544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.